Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-1827
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma ; volume:122 ; number:5 ; day:20 ; month:12 ; year:2019 ; pages:630-633 ; date:3.2020
British journal of cancer ; 122, Heft 5 (20.12.2019), 630-633, 3.2020
- Urheber
-
Yi, Sang-Wook
Kim, Se Hwa
Han, Ki Jun
Yi, Jee-Jeon
Ohrr, Heechoul
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-019-0691-3
- URN
-
urn:nbn:de:101:1-2021012517470969086247
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yi, Sang-Wook
- Kim, Se Hwa
- Han, Ki Jun
- Yi, Jee-Jeon
- Ohrr, Heechoul
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of prescription size on statin adherence and cholesterol levels
Decreasing cholesterol levels in the community – lifestyle change with statin?
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Serum Pooling Lowers Cholesterol Recovery
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
Dysregulated cholesterol regulatory genes in hepatocellular carcinoma
Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
A novel cholesterol metabolism-related ferroptosis pathway in hepatocellular carcinoma
Impact of prescription size on statin adherence and cholesterol levels
Decreasing cholesterol levels in the community – lifestyle change with statin?
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Serum Pooling Lowers Cholesterol Recovery
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
Dysregulated cholesterol regulatory genes in hepatocellular carcinoma
Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
A novel cholesterol metabolism-related ferroptosis pathway in hepatocellular carcinoma
Impact of prescription size on statin adherence and cholesterol levels
Decreasing cholesterol levels in the community – lifestyle change with statin?
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Serum Pooling Lowers Cholesterol Recovery
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
Dysregulated cholesterol regulatory genes in hepatocellular carcinoma
Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events